Incontinenza urinaria (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Incontinenza urinaria" in Italian language version.

refsWebsite

Global rank Italian rank

28nih.gov

4^th place

9^th place

17doi.org

2^nd place

7^th place

16oadoi.org

799^th place

22^nd place

3repubblica.it

78^th place

2^nd place

2archive.org

6^th place

8^th place

1web.archive.org

1^st place

1dailee-care.it

low place

1fda.gov

447^th place

644^th place

1pharmastar.it

low place

7,927^th place

archive.org

E. Sacco, T. Prayer-Galetti; F. Pinto; S. Fracalanza; G. Betto; F. Pagano; W. Artibani, Urinary incontinence after radical prostatectomy: incidence by definition, risk factors and temporal trend in a large series with a long-term follow-up., in BJU Int, vol. 97, n. 6, Giu 2006, pp. 1234-41, DOI:10.1111/j.1464-410X.2006.06185.x, PMID 16686718.
HA. Fink, BC. Taylor; JW. Tacklind; IR. Rutks; TJ. Wilt, Treatment interventions in nursing home residents with urinary incontinence: a systematic review of randomized trials., in Mayo Clin Proc, vol. 83, n. 12, dicembre 2008, pp. 1332-43, PMID 19046552.

dailee-care.it

Incontinenza urinaria da sforzo femminile: diagnosi e trattamenti, su dailee-care.it, 23 giugno 2021.

doi.org

dx.doi.org

E. Sacco, T. Prayer-Galetti; F. Pinto; S. Fracalanza; G. Betto; F. Pagano; W. Artibani, Urinary incontinence after radical prostatectomy: incidence by definition, risk factors and temporal trend in a large series with a long-term follow-up., in BJU Int, vol. 97, n. 6, Giu 2006, pp. 1234-41, DOI:10.1111/j.1464-410X.2006.06185.x, PMID 16686718.
E. Sacco, [Physiopathology of overactive bladder syndrome]., in Urologia, vol. 79, n. 1, 2012, pp. 24-35, DOI:10.5301/RU.2012.8972, PMID 22287269.
E. Sacco, R. Bientinesi; F. Marangi; A. D'Addessi; M. Racioppi; G. Gulino; F. Pinto; A. Totaro; P. Bassi, [Overactive bladder syndrome: the social and economic perspective]., in Urologia, vol. 78, n. 4, pp. 241-56, DOI:10.5301/RU.2011.8886, PMID 22237808.
D. Tienforti, E. Sacco; F. Marangi; A. D'Addessi; M. Racioppi; G. Gulino; F. Pinto; A. Totaro; D. D'Agostino; P. Bassi, Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial., in BJU Int, vol. 110, n. 7, Ott 2012, pp. 1004-10, DOI:10.1111/j.1464-410X.2012.10948.x, PMID 22332815.
M. Vij, D. Robinson; L. Cardozo, Emerging drugs for treatment of urinary incontinence., in Expert Opin Emerg Drugs, vol. 15, n. 2, giugno 2010, pp. 299-308, DOI:10.1517/14728211003752702, PMID 20384545.
B. Mihaylova, R. Pitman; D. Tincello; H. van der Vaart; R. Tunn; L. Timlin; D. Quail; A. Johns; M. Sculpher, Cost-effectiveness of duloxetine: the Stress Urinary Incontinence Treatment (SUIT) study., in Value Health, vol. 13, n. 5, agosto 2010, pp. 565-72, DOI:10.1111/j.1524-4733.2010.00729.x, PMID 20456715.
T. Kitta, M. Miyazato; MB. Chancellor; WC. de Groat; K. Nonomura; N. Yoshimura, Alpha2-adrenoceptor blockade potentiates the effect of duloxetine on sneeze induced urethral continence reflex in rats., in J Urol, vol. 184, n. 2, agosto 2010, pp. 762-8, DOI:10.1016/j.juro.2010.03.106, PMID 20639053.
D. Robinson, L. Cardozo, New drug treatments for urinary incontinence., in Maturitas, vol. 65, n. 4, aprile 2010, pp. 340-7, DOI:10.1016/j.maturitas.2009.12.022, PMID 20097022.
BH. Jung, MJ. Jeon; SW. Bai, Hormone-dependent aging problems in women., in Yonsei Med J, vol. 49, n. 3, giugno 2008, pp. 345-51, DOI:10.3349/ymj.2008.49.3.345, PMID 18581581.
SD. Quinn, C. Domoney, The effects of hormones on urinary incontinence in postmenopausal women., in Climacteric, vol. 12, n. 2, aprile 2009, pp. 106-13, DOI:10.1080/13697130802630083, PMID 19259853.
FE. Skjeldestad, B. Hagen, Long-term consequences of gynecological cancer treatment on urinary incontinence: a population-based cross-sectional study., in Acta Obstet Gynecol Scand, vol. 87, n. 4, 2008, pp. 469-75, DOI:10.1080/00016340801948326, PMID 18382876.
JD. Campbell, KS. Gries; JH. Watanabe; A. Ravelo; RR. Dmochowski; SD. Sullivan, Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence., in BMC Urol, vol. 9, 2009, p. 18, DOI:10.1186/1471-2490-9-18, PMID 19930578.
W. Steers, H. Richter; L. Nyberg; J. Kusek; S. Kraus; K. Dandreo; T. Chai; L. Brubaker, Challenges of conducting multi-center, multi-disciplinary urinary incontinence clinical trials: experience of the urinary incontinence treatment network., in Neurourol Urodyn, vol. 28, n. 3, 2009, pp. 170-6, DOI:10.1002/nau.20653, PMID 19030190.
E. Sacco, F. Pinto; P. Bassi, Emerging pharmacological targets in overactive bladder therapy: experimental and clinical evidences., in Int Urogynecol J Pelvic Floor Dysfunct, vol. 19, n. 4, Apr 2008, pp. 583-98, DOI:10.1007/s00192-007-0529-z, PMID 18196198.
E. Sacco, R. Bientinesi, Mirabegron: a review of recent data and its prospects in the management of overactive bladder., in Ther Adv Urol, vol. 4, n. 6, Dic 2012, pp. 315-24, DOI:10.1177/1756287212457114, PMID 23205058.
C. Roxburgh, J. Cook; N. Dublin, Anticholinergic drugs versus other medications for overactive bladder syndrome in adults., in Cochrane Database Syst Rev, n. 3, 2007, pp. CD003190, DOI:10.1002/14651858.CD003190.pub3, PMID 17636716.
M. Imamura, P. Abrams; C. Bain; B. Buckley; L. Cardozo; J. Cody; J. Cook; S. Eustice; C. Glazener; A. Grant; J. Hay-Smith, Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence., in Health Technol Assess, vol. 14, n. 40, agosto 2010, pp. 1-188, iii-iv, DOI:10.3310/hta14400, PMID 20738930.

fda.gov

FDA approves Botox to treat overactive bladder, su fda.gov, 18 gennaio 2013. URL consultato il 13 dicembre 2013.

nih.gov

ncbi.nlm.nih.gov

E. Sacco, T. Prayer-Galetti; F. Pinto; S. Fracalanza; G. Betto; F. Pagano; W. Artibani, Urinary incontinence after radical prostatectomy: incidence by definition, risk factors and temporal trend in a large series with a long-term follow-up., in BJU Int, vol. 97, n. 6, Giu 2006, pp. 1234-41, DOI:10.1111/j.1464-410X.2006.06185.x, PMID 16686718.
E. Sacco, [Physiopathology of overactive bladder syndrome]., in Urologia, vol. 79, n. 1, 2012, pp. 24-35, DOI:10.5301/RU.2012.8972, PMID 22287269.
E. Sacco, R. Bientinesi; F. Marangi; A. D'Addessi; M. Racioppi; G. Gulino; F. Pinto; A. Totaro; P. Bassi, [Overactive bladder syndrome: the social and economic perspective]., in Urologia, vol. 78, n. 4, pp. 241-56, DOI:10.5301/RU.2011.8886, PMID 22237808.
AF. Adeniyi, JO. Adeleye; CY. Adeniyi, Diabetes, sexual dysfunction and therapeutic exercise: a 20 year review., in Curr Diabetes Rev, vol. 6, n. 4, luglio 2010, pp. 201-6, PMID 20522020.
D. Tienforti, E. Sacco; F. Marangi; A. D'Addessi; M. Racioppi; G. Gulino; F. Pinto; A. Totaro; D. D'Agostino; P. Bassi, Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial., in BJU Int, vol. 110, n. 7, Ott 2012, pp. 1004-10, DOI:10.1111/j.1464-410X.2012.10948.x, PMID 22332815.
Duloxetine: new indication. Depression and diabetic neuropathy: too many adverse effects., in Prescrire Int, vol. 15, n. 85, ottobre 2006, pp. 168-72, PMID 17121211.
M. Vij, D. Robinson; L. Cardozo, Emerging drugs for treatment of urinary incontinence., in Expert Opin Emerg Drugs, vol. 15, n. 2, giugno 2010, pp. 299-308, DOI:10.1517/14728211003752702, PMID 20384545.
B. Mihaylova, R. Pitman; D. Tincello; H. van der Vaart; R. Tunn; L. Timlin; D. Quail; A. Johns; M. Sculpher, Cost-effectiveness of duloxetine: the Stress Urinary Incontinence Treatment (SUIT) study., in Value Health, vol. 13, n. 5, agosto 2010, pp. 565-72, DOI:10.1111/j.1524-4733.2010.00729.x, PMID 20456715.
T. Kitta, M. Miyazato; MB. Chancellor; WC. de Groat; K. Nonomura; N. Yoshimura, Alpha2-adrenoceptor blockade potentiates the effect of duloxetine on sneeze induced urethral continence reflex in rats., in J Urol, vol. 184, n. 2, agosto 2010, pp. 762-8, DOI:10.1016/j.juro.2010.03.106, PMID 20639053.
D. Robinson, L. Cardozo, New drug treatments for urinary incontinence., in Maturitas, vol. 65, n. 4, aprile 2010, pp. 340-7, DOI:10.1016/j.maturitas.2009.12.022, PMID 20097022.
BH. Jung, MJ. Jeon; SW. Bai, Hormone-dependent aging problems in women., in Yonsei Med J, vol. 49, n. 3, giugno 2008, pp. 345-51, DOI:10.3349/ymj.2008.49.3.345, PMID 18581581.
SD. Quinn, C. Domoney, The effects of hormones on urinary incontinence in postmenopausal women., in Climacteric, vol. 12, n. 2, aprile 2009, pp. 106-13, DOI:10.1080/13697130802630083, PMID 19259853.
FE. Skjeldestad, B. Hagen, Long-term consequences of gynecological cancer treatment on urinary incontinence: a population-based cross-sectional study., in Acta Obstet Gynecol Scand, vol. 87, n. 4, 2008, pp. 469-75, DOI:10.1080/00016340801948326, PMID 18382876.
D. Robinson, L. Cardozo, The menopause and HRT. Urogenital effects of hormone therapy., in Best Pract Res Clin Endocrinol Metab, vol. 17, n. 1, marzo 2003, pp. 91-104, PMID 12763514.
M. Yoshida, K. Masunaga; T. Nagata; M. Yono; Y. Homma, The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: pathophysiology and pharmacotherapy of overactive bladder., in J Pharmacol Sci, vol. 112, n. 2, 2010, pp. 128-34, PMID 20134115.
JD. Campbell, KS. Gries; JH. Watanabe; A. Ravelo; RR. Dmochowski; SD. Sullivan, Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence., in BMC Urol, vol. 9, 2009, p. 18, DOI:10.1186/1471-2490-9-18, PMID 19930578.
HA. Fink, BC. Taylor; JW. Tacklind; IR. Rutks; TJ. Wilt, Treatment interventions in nursing home residents with urinary incontinence: a systematic review of randomized trials., in Mayo Clin Proc, vol. 83, n. 12, dicembre 2008, pp. 1332-43, PMID 19046552.
W. Steers, H. Richter; L. Nyberg; J. Kusek; S. Kraus; K. Dandreo; T. Chai; L. Brubaker, Challenges of conducting multi-center, multi-disciplinary urinary incontinence clinical trials: experience of the urinary incontinence treatment network., in Neurourol Urodyn, vol. 28, n. 3, 2009, pp. 170-6, DOI:10.1002/nau.20653, PMID 19030190.
E. Sacco, F. Pinto; P. Bassi, Emerging pharmacological targets in overactive bladder therapy: experimental and clinical evidences., in Int Urogynecol J Pelvic Floor Dysfunct, vol. 19, n. 4, Apr 2008, pp. 583-98, DOI:10.1007/s00192-007-0529-z, PMID 18196198.
E. Sacco, F. Pinto; D. Tienforti; F. Marangi; A. Destito; M. Racioppi; M. Gardi; A. Volpi; PF. Bassi, [Investigational drug therapies for overactive bladder syndrome: the potential alternatives to anticolinergics.], in Urologia, vol. 76, n. 3, pp. 161-177, PMID 21086288.
E. Sacco, R. Bientinesi, Mirabegron: a review of recent data and its prospects in the management of overactive bladder., in Ther Adv Urol, vol. 4, n. 6, Dic 2012, pp. 315-24, DOI:10.1177/1756287212457114, PMID 23205058.
MC. Michel, HG. Ruhe; AA. de Groot; R. Castro; M. Oelke, Tolerability of amine uptake inhibitors in urologic diseases., in Curr Drug Saf, vol. 1, n. 1, gennaio 2006, pp. 73-85, PMID 18690917.
C. Roxburgh, J. Cook; N. Dublin, Anticholinergic drugs versus other medications for overactive bladder syndrome in adults., in Cochrane Database Syst Rev, n. 3, 2007, pp. CD003190, DOI:10.1002/14651858.CD003190.pub3, PMID 17636716.
M. Vella, D. Robinson; L. Cardozo; R. Cartwright, New developments in the treatment of urinary incontinence., in Minerva Urol Nefrol, vol. 58, n. 4, dicembre 2006, pp. 299-310, PMID 17268395.
CS. Iosif, Effects of protracted administration of estriol on the lower genito urinary tract in postmenopausal women., in Arch Gynecol Obstet, vol. 251, n. 3, 1992, pp. 115-20, PMID 1605675.
M. Imamura, P. Abrams; C. Bain; B. Buckley; L. Cardozo; J. Cody; J. Cook; S. Eustice; C. Glazener; A. Grant; J. Hay-Smith, Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence., in Health Technol Assess, vol. 14, n. 40, agosto 2010, pp. 1-188, iii-iv, DOI:10.3310/hta14400, PMID 20738930.
GJ. Jarvis, Surgery for genuine stress incontinence., in Br J Obstet Gynaecol, vol. 101, n. 5, Mag 1994, pp. 371-4, PMID 8018606.
E. Sacco, M. Paolillo; A. Totaro; F. Pinto; A. Volpe; M. Gardi; PF. Bassi, [Botulinum toxin in the treatment of overactive bladder.], in Urologia, vol. 75, n. 1, pp. 4-13, PMID 21086369.

oadoi.org

E. Sacco, [Physiopathology of overactive bladder syndrome]., in Urologia, vol. 79, n. 1, 2012, pp. 24-35, DOI:10.5301/RU.2012.8972, PMID 22287269.
E. Sacco, R. Bientinesi; F. Marangi; A. D'Addessi; M. Racioppi; G. Gulino; F. Pinto; A. Totaro; P. Bassi, [Overactive bladder syndrome: the social and economic perspective]., in Urologia, vol. 78, n. 4, pp. 241-56, DOI:10.5301/RU.2011.8886, PMID 22237808.
D. Tienforti, E. Sacco; F. Marangi; A. D'Addessi; M. Racioppi; G. Gulino; F. Pinto; A. Totaro; D. D'Agostino; P. Bassi, Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial., in BJU Int, vol. 110, n. 7, Ott 2012, pp. 1004-10, DOI:10.1111/j.1464-410X.2012.10948.x, PMID 22332815.
M. Vij, D. Robinson; L. Cardozo, Emerging drugs for treatment of urinary incontinence., in Expert Opin Emerg Drugs, vol. 15, n. 2, giugno 2010, pp. 299-308, DOI:10.1517/14728211003752702, PMID 20384545.
B. Mihaylova, R. Pitman; D. Tincello; H. van der Vaart; R. Tunn; L. Timlin; D. Quail; A. Johns; M. Sculpher, Cost-effectiveness of duloxetine: the Stress Urinary Incontinence Treatment (SUIT) study., in Value Health, vol. 13, n. 5, agosto 2010, pp. 565-72, DOI:10.1111/j.1524-4733.2010.00729.x, PMID 20456715.
T. Kitta, M. Miyazato; MB. Chancellor; WC. de Groat; K. Nonomura; N. Yoshimura, Alpha2-adrenoceptor blockade potentiates the effect of duloxetine on sneeze induced urethral continence reflex in rats., in J Urol, vol. 184, n. 2, agosto 2010, pp. 762-8, DOI:10.1016/j.juro.2010.03.106, PMID 20639053.
D. Robinson, L. Cardozo, New drug treatments for urinary incontinence., in Maturitas, vol. 65, n. 4, aprile 2010, pp. 340-7, DOI:10.1016/j.maturitas.2009.12.022, PMID 20097022.
BH. Jung, MJ. Jeon; SW. Bai, Hormone-dependent aging problems in women., in Yonsei Med J, vol. 49, n. 3, giugno 2008, pp. 345-51, DOI:10.3349/ymj.2008.49.3.345, PMID 18581581.
SD. Quinn, C. Domoney, The effects of hormones on urinary incontinence in postmenopausal women., in Climacteric, vol. 12, n. 2, aprile 2009, pp. 106-13, DOI:10.1080/13697130802630083, PMID 19259853.
FE. Skjeldestad, B. Hagen, Long-term consequences of gynecological cancer treatment on urinary incontinence: a population-based cross-sectional study., in Acta Obstet Gynecol Scand, vol. 87, n. 4, 2008, pp. 469-75, DOI:10.1080/00016340801948326, PMID 18382876.
JD. Campbell, KS. Gries; JH. Watanabe; A. Ravelo; RR. Dmochowski; SD. Sullivan, Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence., in BMC Urol, vol. 9, 2009, p. 18, DOI:10.1186/1471-2490-9-18, PMID 19930578.
W. Steers, H. Richter; L. Nyberg; J. Kusek; S. Kraus; K. Dandreo; T. Chai; L. Brubaker, Challenges of conducting multi-center, multi-disciplinary urinary incontinence clinical trials: experience of the urinary incontinence treatment network., in Neurourol Urodyn, vol. 28, n. 3, 2009, pp. 170-6, DOI:10.1002/nau.20653, PMID 19030190.
E. Sacco, F. Pinto; P. Bassi, Emerging pharmacological targets in overactive bladder therapy: experimental and clinical evidences., in Int Urogynecol J Pelvic Floor Dysfunct, vol. 19, n. 4, Apr 2008, pp. 583-98, DOI:10.1007/s00192-007-0529-z, PMID 18196198.
E. Sacco, R. Bientinesi, Mirabegron: a review of recent data and its prospects in the management of overactive bladder., in Ther Adv Urol, vol. 4, n. 6, Dic 2012, pp. 315-24, DOI:10.1177/1756287212457114, PMID 23205058.
C. Roxburgh, J. Cook; N. Dublin, Anticholinergic drugs versus other medications for overactive bladder syndrome in adults., in Cochrane Database Syst Rev, n. 3, 2007, pp. CD003190, DOI:10.1002/14651858.CD003190.pub3, PMID 17636716.
M. Imamura, P. Abrams; C. Bain; B. Buckley; L. Cardozo; J. Cody; J. Cook; S. Eustice; C. Glazener; A. Grant; J. Hay-Smith, Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence., in Health Technol Assess, vol. 14, n. 40, agosto 2010, pp. 1-188, iii-iv, DOI:10.3310/hta14400, PMID 20738930.

pharmastar.it

PHARMASTAR : Fda approva tossina botulinica contro l'incontinenza resistente agli anticolinergici, su pharmastar.it. URL consultato il 27 gennaio 2013.

repubblica.it

ricerca.repubblica.it

Elvira Naselli, Urologia, in la Repubblica, 12 marzo 2013, p. 38.
Alessandra Margreth, Incontinenza, in la Repubblica, 28 giugno 2011, p. 36.
Elvira Naselli, Urologia, in la Repubblica, 17 maggio 2011, p. 43.

web.archive.org

"Managing Urinary Incontinence". National Prescribing Service, available at Copia archiviata, su nps.org.au. URL consultato il 24 settembre 2013 (archiviato dall'url originale il 30 giugno 2012).